Small Molecules
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
64
NCT04836195
Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 14, 2021
Completion: Oct 28, 2024
NCT06613217
Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia
Start: Mar 3, 2025
Completion: Sep 1, 2026
Loading map...